Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.
about
In vivo processing of ceria nanoparticles inside liver: impact on free-radical scavenging activity and oxidative stressProgress and perspectives on targeting nanoparticles for brain drug delivery.Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Gold Nanoparticles in Single-Cell Analysis for Surface Enhanced Raman ScatteringNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsRole of Physicochemical Properties in Nanoparticle ToxicityTheranostic Performance of Acoustic Nanodroplet Vaporization-Generated Bubbles in Tumor Intertissue.Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsNanoparticles for live cell microscopy: A surface-enhanced Raman scattering perspective.Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies.Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approachMeasuring Binding Kinetics of Antibody-Conjugated Gold Nanoparticles with Intact Cells.Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting.Combined use of AFM and soft X-ray microscopy to reveal fibres' internalization in mesothelial cells.Intracellular trafficking pathways in silver nanoparticle uptake and toxicity in Caenorhabditis elegansCore-shell nanocarriers with high paclitaxel loading for passive and active targeting.Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes.Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs.Pretreatment with chemotherapeutics for enhanced nanoparticles accumulation in tumor: the potential role of G2 cycle retention effect.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Advances in targeting strategies for nanoparticles in cancer imaging and therapy.Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics.Nanoparticle-based luminescent probes for intracellular sensing and imaging of pH.Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier Model.Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticlesPerspectives on Dual Targeting Delivery Systems for Brain Tumors.Dendritic nanoconjugates of photosensitizer for targeted photodynamic therapy.Effect of new curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses.Clathrin-mediated endocytosis of gold nanoparticles in vitro.An update on applications of nanostructured drug delivery systems in cancer therapy: a review.Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.Earthworm coelomocytes as nanoscavenger of ZnO NPs.Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
P2860
Q23923045-E3A37C2E-F8FE-4408-A055-123E0CE4E9DAQ26740580-F39069C3-CA8A-4DA9-8C05-0D629C7D12C1Q27002209-0B1C9554-4151-40E1-89C5-DDBC40A6FD44Q28079121-ED807A97-37E4-4255-8C6B-E8B4D80EFE5CQ28818166-0243DA06-839B-481D-9B89-0768C76F2CBBQ29248830-5A0EF94A-07AC-4634-AFAC-B5E0D024A89FQ30356036-C57D315F-7538-4CAB-B4E8-EB0908109A18Q30387307-A8073FF6-911B-4A92-92F3-5ACF22C4E0AFQ33766557-B781A898-7E37-4143-9EE8-145B43936181Q33807149-9AB27152-2F36-4517-B0F5-B63D57467F4EQ33855309-0724D90B-4226-4B8F-A8C1-355B93061A70Q33860870-2603F3F4-CA23-4774-824B-A10619C2148CQ33861915-6EA1031E-F549-4473-BB1A-052811681009Q35787096-28B7F57A-15FA-4DF9-A2AF-FC743B51234CQ35868357-2AB8DE27-AD52-4CB8-98F7-EAF1810467EEQ36003868-869C6CC4-177E-430F-AF50-6F5982E89F2AQ36062053-CBA4A51A-CE20-44F7-9F7A-4BAF8C58C9FFQ36373011-7D36CCF1-3700-460B-A49A-F9EEECEDEDCCQ36893033-984294B3-0920-4343-8933-BFB8C454496CQ36986079-25C305A0-EE53-442B-A0B6-0EEF3C5BCB77Q37299036-5C93D9EF-2084-4492-A93B-4B322EA18634Q37613811-A15E353A-DEEA-4437-9ADB-747E91B02765Q37666715-F95F289E-D3CE-4BDE-AF30-7F21C14E45CEQ38176391-6DB69062-0B1C-4C79-81F3-E2F01DE3A5F9Q38255901-BA3232F1-37B8-4342-AE53-9C63B9F6A98FQ38283340-BF239E27-23E8-425B-B1C1-5FD3E14D8E1EQ38591300-368C528D-8061-4548-B38F-A9EA5F3F8E27Q38712188-4A954193-9D31-4EEC-B2DD-8F3489D600C2Q38781423-E5DC489B-3BFD-4CA8-816A-42846FA95178Q38827940-E44D2BF4-1A65-42C5-861D-033B02D1218AQ38833609-2B4B508A-D889-416F-B6F6-441912DEB110Q38857119-B1F24293-A0F7-4556-ADF9-7FB831933029Q38883747-9ED8B566-D1BD-4D9A-9E6D-046A87A283BEQ38895315-FA860B9D-A9A2-4BD7-A154-A11D71170352Q38954334-96A392D4-952B-4B15-96B8-A00D799AF02AQ38955323-F5D1C6C9-B053-4F8C-BEEA-C139CE1AE06BQ39025424-35D2A9C5-045C-484A-B94D-BB99C88ACDCCQ39375298-BA59E65E-4455-4DF5-804B-A5F86448431CQ40806461-AE85282A-FC85-490C-B9B3-5854E6930D31Q40899589-54D13B38-369E-49E7-A07C-75FB359C4646
P2860
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ligand modified nanoparticles ...... tribution and internalization.
@ast
Ligand modified nanoparticles ...... tribution and internalization.
@en
type
label
Ligand modified nanoparticles ...... tribution and internalization.
@ast
Ligand modified nanoparticles ...... tribution and internalization.
@en
prefLabel
Ligand modified nanoparticles ...... tribution and internalization.
@ast
Ligand modified nanoparticles ...... tribution and internalization.
@en
P2093
P2860
P356
P1433
P1476
Ligand modified nanoparticles ...... tribution and internalization.
@en
P2093
Shijie Cao
Shuang Zhang
Xinguo Jiang
Zhiqing Pang
P2860
P2888
P356
10.1038/SREP02534
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1005921645